• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cannabinoid pharmacology and its therapeutic uses in Alzheimer's disease.

作者信息

Monteiro Kadja Luana Chagas, Dos Santos Alcântara Marcone Gomes, de Aquino Thiago Mendonça, da Silva-Júnior Edeildo Ferreira

机构信息

Laboratory of Medicinal Chemistry, Institute of Pharmaceutical Sciences, Federal University of Alagoas, Maceió, Brazil.

Chemistry and Biotechnology Institute, Federal University of Alagoas, Maceió, Brazil.

出版信息

Neural Regen Res. 2021 May;16(5):990-991. doi: 10.4103/1673-5374.294336.

DOI:10.4103/1673-5374.294336
PMID:33229747
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8178768/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49c8/8178768/b5b4344794ce/NRR-16-990-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49c8/8178768/b5b4344794ce/NRR-16-990-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/49c8/8178768/b5b4344794ce/NRR-16-990-g001.jpg

相似文献

1
Cannabinoid pharmacology and its therapeutic uses in Alzheimer's disease.大麻素药理学及其在阿尔茨海默病中的治疗用途。
Neural Regen Res. 2021 May;16(5):990-991. doi: 10.4103/1673-5374.294336.
2
Impact of the Cannabinoid System in Alzheimer's Disease.大麻素系统对阿尔茨海默病的影响。
Curr Neuropharmacol. 2023;21(3):715-726. doi: 10.2174/1570159X20666220201091006.
3
Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease.靶向大麻素系统以对抗阿尔茨海默病中应激的有害影响。
Front Aging Neurosci. 2022 Oct 4;14:949361. doi: 10.3389/fnagi.2022.949361. eCollection 2022.
4
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease.阿尔茨海默病中内源性大麻素信号的分子重排。
Brain. 2011 Apr;134(Pt 4):1041-60. doi: 10.1093/brain/awr046.
5
Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system.大麻素在影响中枢神经系统的慢性退行性疾病中的药理学/治疗学。
Biochem Pharmacol. 2018 Nov;157:67-84. doi: 10.1016/j.bcp.2018.08.016. Epub 2018 Aug 17.
6
Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer's disease.整合网络药理学与分子对接以探究虫草素治疗阿尔茨海默病的分子机制。
Front Aging Neurosci. 2022 Dec 23;14:1058780. doi: 10.3389/fnagi.2022.1058780. eCollection 2022.
7
Identification of phytochemicals from North African plants for treating Alzheimer's diseases and of their molecular targets by in silico network pharmacology approach.通过计算机网络药理学方法从北非植物中鉴定用于治疗阿尔茨海默病的植物化学物质及其分子靶点。
J Tradit Complement Med. 2020 Aug 12;11(3):268-278. doi: 10.1016/j.jtcme.2020.08.002. eCollection 2021 May.
8
Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains.大麻素受体在人脑内的结合及信使核糖核酸表达：对正常老年脑和阿尔茨海默病脑的体外受体放射自显影及原位杂交组织化学研究
Neuroscience. 1994 Dec;63(3):637-52. doi: 10.1016/0306-4522(94)90511-8.
9
Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer's Disease and Less Well-Known Diseases.大麻素受体作为阿尔茨海默病和鲜为人知疾病治疗靶点的创新治疗潜力。
Curr Med Chem. 2019;26(18):3300-3340. doi: 10.2174/0929867325666180226095132.
10
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease.新型吲唑衍生物通过激活大麻素受体 2 使晚发性阿尔茨海默病患者的淋巴母细胞存活模式正常化。
CNS Drugs. 2018 Jun;32(6):579-591. doi: 10.1007/s40263-018-0515-7.

引用本文的文献

1
Anti-Inflammatory Effects of Cannabinoids in Therapy of Neurodegenerative Disorders and Inflammatory Diseases of the CNS.大麻素在神经退行性疾病和中枢神经系统炎症性疾病治疗中的抗炎作用。
Int J Mol Sci. 2025 Jul 8;26(14):6570. doi: 10.3390/ijms26146570.
2
Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.大麻素：在神经系统疾病和精神障碍中的作用
Int J Mol Sci. 2024 Dec 27;26(1):152. doi: 10.3390/ijms26010152.
3
A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease across a Decade of Research.

本文引用的文献

1
Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.概述大麻二酚 (CBD) 及其类似物：结构、生物活性以及在癫痫和阿尔茨海默病中的神经保护机制。
Eur J Med Chem. 2020 Apr 15;192:112163. doi: 10.1016/j.ejmech.2020.112163. Epub 2020 Feb 22.
2
Cannabidiol: Recent advances and new insights for neuropsychiatric disorders treatment.大麻二酚：神经精神疾病治疗的最新进展和新见解。
Life Sci. 2019 May 1;224:120-127. doi: 10.1016/j.lfs.2019.03.053. Epub 2019 Mar 22.
3
Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells.
全面探索大麻素在阿尔茨海默病中的多方面神经保护作用：十年研究综述。
Int J Mol Sci. 2024 Aug 7;25(16):8630. doi: 10.3390/ijms25168630.
4
The Influence of an Acute Administration of Cannabidiol or Rivastigmine, Alone and in Combination, on Scopolamine-Provoked Memory Impairment in the Passive Avoidance Test in Mice.急性给予大麻二酚或卡巴拉汀单独及联合应用对东莨菪碱诱发的小鼠被动回避试验记忆损伤的影响。
Pharmaceuticals (Basel). 2024 Jun 20;17(6):809. doi: 10.3390/ph17060809.
5
Impact of the Cannabinoid System in Alzheimer's Disease.大麻素系统对阿尔茨海默病的影响。
Curr Neuropharmacol. 2023;21(3):715-726. doi: 10.2174/1570159X20666220201091006.
大麻二酚调节间充质干细胞中与阿尔茨海默病相关基因的表达。
Int J Mol Sci. 2016 Dec 23;18(1):26. doi: 10.3390/ijms18010026.
4
The potential therapeutic effects of THC on Alzheimer's disease.四氢大麻酚对阿尔茨海默病的潜在治疗作用。
J Alzheimers Dis. 2014;42(3):973-84. doi: 10.3233/JAD-140093.
5
Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.大麻素对β淀粉样纤维和聚集体形成、体外神经元和小胶质细胞激活的神经毒性的影响。
Cell Mol Neurobiol. 2014 Jan;34(1):31-42. doi: 10.1007/s10571-013-9984-x. Epub 2013 Sep 13.
6
Natural cannabinoids improve dopamine neurotransmission and tau and amyloid pathology in a mouse model of tauopathy.天然大麻素可改善tau 病小鼠模型中的多巴胺神经传递以及tau 和淀粉样蛋白病理。
J Alzheimers Dis. 2013;35(3):525-39. doi: 10.3233/JAD-130050.
7
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.大麻二酚通过 PPARγ 参与减少 Aβ 诱导的神经炎症并促进海马神经发生。
PLoS One. 2011;6(12):e28668. doi: 10.1371/journal.pone.0028668. Epub 2011 Dec 5.
8
Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.大麻二酚和其他大麻素可减少体外和体内小胶质细胞的激活：与阿尔茨海默病相关。
Mol Pharmacol. 2011 Jun;79(6):964-73. doi: 10.1124/mol.111.071290. Epub 2011 Feb 24.
9
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults.内源性大麻素 2-花生四烯酰甘油能保护神经元免受β-淀粉样肽的侵害。
Neuroscience. 2011 Mar 31;178:159-68. doi: 10.1016/j.neuroscience.2011.01.024. Epub 2011 Jan 19.
10
CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.CB1受体选择性激活可抑制β-淀粉样蛋白诱导的C6细胞中诱导型一氧化氮合酶蛋白表达，并随后减弱共培养神经元中tau蛋白的过度磷酸化。
Neurosci Lett. 2006 Sep 1;404(3):342-6. doi: 10.1016/j.neulet.2006.06.012. Epub 2006 Jul 11.